Stockscreener 앱 받기
0.30
6.75%
-0.0217
시간 외 거래:
.32
0.02
+6.67%
Cue Biopharma Inc 주식(CUE)의 최신 뉴스
Cue Biopharma appoints industry veteran Lucinda Warren as chief financial and business officer - marketscreener.com
Cue Biopharma (CUE) Appoints New Chief Financial and Business Of - GuruFocus
Cue Biopharma, Inc. Appoints Lucinda Warren as Chief Financial Officer, Effective February 9, 2026 - marketscreener.com
Cue Biopharma Names Lucinda Warren Chief Financial Officer - TipRanks
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer - bitget.com
Can Cue Biopharma Inc outperform in the next rallyJuly 2025 Chart Watch & Daily Stock Momentum Reports - baoquankhu1.vn
What’s the RSI of Cue Biopharma Inc. stockQuarterly Growth Report & Reliable Breakout Forecasts - mfd.ru
Is Cue Biopharma Inc. stock forming a triangle pattern2025 Market WrapUp & AI Driven Stock Movement Reports - mfd.ru
Volatility Watch: Is Cue Biopharma Inc forming a bullish divergence2025 Price Targets & Weekly High Potential Stock Alerts - baoquankhu1.vn
CUE Stock Price, Forecast & Analysis | CUE BIOPHARMA INC (NASDAQ:CUE) - Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq
Options Flow: Can Cue Biopharma Inc disrupt its industryMarket Risk Analysis & Risk Managed Investment Strategies - baoquankhu1.vn
Is Cue Biopharma Inc. (1UC) stock overpriced at current multiples2025 Trading Volume Trends & Growth Oriented Trading Recommendations - bollywoodhelpline.com
Is Cue Biopharma Inc benefiting from interest rate changesInsider Buying & Daily Stock Momentum Reports - baoquankhu1.vn
Cue Biopharma (NASDAQ:CUE) Shares Up 9% – Should You Buy? - Defense World
Activity Recap: Whats the profit margin of Cue Biopharma IncJuly 2025 Short Interest & Low Drawdown Momentum Ideas - baoquankhu1.vn
Analyst Upgrade: Can Cue Biopharma Inc be recession proofJuly 2025 Snapshot & Daily Growth Stock Investment Tips - baoquankhu1.vn
Cue Biopharma launches proposed public offering of shares and warrants - MSN
Can Cue Biopharma Inc. stock outperform in 2025 bull marketWeekly Investment Recap & AI Driven Price Forecasts - Улправда
How sustainable is Cue Biopharma Inc. stock dividend payout2025 Growth vs Value & Short-Term Trading Alerts - Улправда
Why Cue Biopharma Inc. stock is trending among retail tradersStock Surge & Verified Momentum Stock Ideas - Улправда
What sentiment indicators say about Cue Biopharma Inc. stock2025 Pullback Review & Reliable Momentum Entry Alerts - Улправда
Aug Big Picture: Why Cue Biopharma Inc. stock remains resilient2025 Top Gainers & Consistent Return Strategy Ideas - Улправда
Why Cue Biopharma Inc. stock remains resilientJuly 2025 Highlights & Free Safe Capital Growth Stock Tips - Улправда
Will Cue Biopharma Inc. stock see insider buyingStop Loss Placement Tips & Small Entry Cost Investments - Улправда
Institution Moves: Will Cue Biopharma Inc 1UC stock benefit from mergersTrade Risk Assessment & AI Forecast Swing Trade Picks - Bộ Nội Vụ
Is Cue Biopharma Inc. stock attractive for growth ETFs2026 world cup usa national team semifinals top scorers high defensive line tactical prediction expert opinion - Улправда
2026 world cup lineups insights: Will Cue Biopharma Inc. stock benefit from AI adoption2026 world cup usa national team round of 32 young talents transition play tactical prediction insights - ulpravda.ru
EBIT per share of Cue Biopharma, Inc. – SWB:1UC - TradingView — Track All Markets
CUE Insider Trading - Quiver Quantitative
Is Cue Biopharma Inc a good long term investmentStock Screening Results & Big Gains Low Budget - earlytimes.in
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Cue Biopharma stock: niche immunotherapy bet caught in a bruising small-cap biotech storm - AD HOC NEWS
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Cue Biopharma (CUE) price target increased by 25.00% to 5.10 - MSN
Working capital per share of Cue Biopharma, Inc. – SWB:1UC - TradingView — Track All Markets
Cue Biopharma prices $10M underwritten public offering; shares down - MSN
Can Cue Biopharma Inc. stock rebound after recent weaknessTreasury Yields & Verified Swing Trading Watchlists - Улправда
How Cue Biopharma Inc. (1UC) stock reacts to stronger dollarMarket Activity Report & Risk Controlled Swing Trade Alerts - Улправда
Published on: 2025-12-20 23:54:48 - moha.gov.vn
Cue Biopharma Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Cue Biopharma Signs Underwriting Agreement With H.C. Wainwright & Co. - TradingView — Track All Markets
Cue Biopharma prices $10 million public offering at $0.28 per share - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Cue Biopharma (CUE) Launches $10 Million Public Offering with Wa - GuruFocus
Cue Biopharma prices 35.7M shares at 28c in underwritten public offering - TipRanks
Cue Biopharma (CUE) Launches $10 Million Public Offering with Warrants - GuruFocus
Cue Biopharma announces pricing of $10 million public offering - marketscreener.com
Why retail investors pile into Cue Biopharma Inc. stock2025 Valuation Update & Safe Capital Growth Plans - ulpravda.ru
Cue Biopharma Announces Pricing of $10 Million Public Offering - GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Is Cue Biopharma Inc. (1UC) stock undervalued by metricsPortfolio Risk Report & Precise Trade Entry Recommendations - DonanımHaber
Why Cue Biopharma Inc. stock is seen as undervalued2025 Buyback Activity & Fast Gaining Stock Strategy Reports - DonanımHaber
1.24%
0.19%
자본화:
|
볼륨(24시간):